 MIAMI, Dec. 28, 2020 GLOBE NEWSWIRE -- Ehave, Inc. OTC Pink: EHVVF the Company, a leader in digital therapeutics and developer of KetaDASH, a home delivery platform for patients who have been prescribed Ketamine infusions, announced today the Companys Board of directors has elected to sell 100 of its Mycotopia Therapies subsidiary to 2020 Global Inc. OTC Pink: TWGL for 350,000 while simultaneously acquiring approximately 75.77 of 2020 Globals outstanding shares from 2020 Globals management. 